Insufficient sleep may significantly elevate the risk of atrial fibrillation (AF), the most common type of heart rhythm disorder, particularly among adults in their 50s, according to a modern study by researchers at Kumamoto University and the National Cerebral and Cardiovascular Center in Japan.
The research, which utilized a one-week Holter electrocardiogram with an accelerometer to objectively measure sleep duration, revealed a strong correlation between shorter sleep and increased AF likelihood in working-age individuals. Each additional minute of sleep was associated with a measurable reduction in AF risk within this demographic. Notably, the study found no such clear association among participants in their 70s.
While increased sleep duration generally lowered AF risk, the study indicated that excessively long sleep did not provide additional benefit, especially in older adults. This suggests that the cardiovascular benefits of sleep are most pronounced when addressing sleep deficiency, rather than simply maximizing total sleep time.
Atrial fibrillation is a condition that can lead to stroke and heart failure, making it a serious health concern. Effective management of AF often relies on oral anticoagulation therapy to prevent stroke, but adherence to such medication can be a challenge, as highlighted in a prospective cohort study of Japanese AF patients taking rivaroxaban. That study, conducted by researchers at the National Cerebral and Cardiovascular Center and Kumamoto University Hospital, found that poor adherence to anticoagulation was independently associated with higher rates of stroke, systemic embolism, major bleeding, and a composite measure of adverse clinical outcomes.
“Our results provide objective evidence that sleep duration matters for heart rhythm health, particularly in working adults,” said Dr. Tadashi Hoshiyama of Kumamoto University. “Securing sufficient sleep may help reduce the burden of atrial fibrillation.”
The National Cerebral and Cardiovascular Center has also recently published research on the benefits and risks of continuing oral anticoagulation therapy after catheter ablation for atrial fibrillation, further emphasizing the complex interplay between heart rhythm management and patient health factors.
